EBMT transplantation risk score
Prognostic factors . | Risk score . |
|---|---|
| Age | |
| Less than 20 y | 0 |
| 20-40 y | 1 |
| More than 40 y | 2 |
| Interval from diagnosis to HSCT | |
| 1 y or less | 0 |
| More than 1 y | 1 |
| Disease phase | |
| Chronic | 0 |
| Accelerated | 1 |
| Blastic | 2 |
| Donor-recipient sex match | |
| Female donor and male | |
| recipient | 1 |
| Any other match | 0 |
| Donor type | |
| HLA-identical sibling | 0 |
| Any other | 1 |
Prognostic factors . | Risk score . |
|---|---|
| Age | |
| Less than 20 y | 0 |
| 20-40 y | 1 |
| More than 40 y | 2 |
| Interval from diagnosis to HSCT | |
| 1 y or less | 0 |
| More than 1 y | 1 |
| Disease phase | |
| Chronic | 0 |
| Accelerated | 1 |
| Blastic | 2 |
| Donor-recipient sex match | |
| Female donor and male | |
| recipient | 1 |
| Any other match | 0 |
| Donor type | |
| HLA-identical sibling | 0 |
| Any other | 1 |
The table lists the prognostic factors and the corresponding risk score as they were calculated in the original EBMT report40 and in the subsequent CIBMTR study.41